KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Prepaid Assets (2019 - 2025)

Royalty Pharma's Prepaid Assets history spans 7 years, with the latest figure at $6.9 million for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 64.63% year-over-year to $6.9 million; the TTM value through Dec 2025 reached $6.9 million, up 64.63%, while the annual FY2025 figure was $6.9 million, 64.63% up from the prior year.
  • Prepaid Assets for Q4 2025 was $6.9 million at Royalty Pharma, up from $5.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $90.5 million in Q4 2022 and bottomed at $2.3 million in Q2 2024.
  • The 5-year median for Prepaid Assets is $6.6 million (2021), against an average of $18.2 million.
  • The largest annual shift saw Prepaid Assets skyrocketed 1265.1% in 2022 before it plummeted 92.51% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $6.6 million in 2021, then surged by 1265.1% to $90.5 million in 2022, then tumbled by 80.07% to $18.0 million in 2023, then crashed by 76.79% to $4.2 million in 2024, then surged by 64.63% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for RPRX's Prepaid Assets are $6.9 million (Q4 2025), $5.5 million (Q3 2025), and $4.5 million (Q2 2025).